Cancellation of cataract surgery prior to surgery · people with age‐related cataract
Routine preoperative medical testing showed no clear difference in cancellation of cataract surgery prior to surgery compared with selective or no testing (high certainty).
1 finding from 1 review
Clinical management changes (other than cancellation) prior to surgery · people with age‐related cataract
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life outcomes at any · people with age‐related cataract
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Primary retinal reattachment at least 3 months after operation · people with simple rhegmatogenous retinal detachments
Pars plana vitrectomy (PPV) showed no clear difference in primary retinal reattachment at least 3 months after operation compared with scleral buckling (low certainty).
1 finding from 1 review
Visual acuity · people with simple rhegmatogenous retinal detachments
1 finding from 1 review
Final anatomical success at least 3 months after operation · people with simple rhegmatogenous retinal detachments
Pars plana vitrectomy (PPV) showed no clear difference in final anatomical success at least 3 months after operation compared with scleral buckling (low certainty).
1 finding from 1 review
Recurrence of retinal detachment at least 3 months after operation · people with simple rhegmatogenous retinal detachments
Pars plana vitrectomy (PPV) may leads to lower recurrence of retinal detachment at least 3 months after operation compared with scleral buckling (low certainty).
1 finding from 1 review
Number of interventions needed to achieve final anatomical success at final · people with simple rhegmatogenous retinal detachments
1 finding from 1 review
Quality of life (satisfaction with vision) at least 3 months after operation · people with simple rhegmatogenous retinal detachments
It is very uncertain whether pars plana vitrectomy (PPV) changes quality of life (satisfaction with vision) at least 3 months after… compared with scleral buckling (very low certainty).
1 finding from 1 review
Adverse effects (cataract development, choroidal detachment, new/iatrogenic breaks, postoperative proliferative vitreoretinopathy, postoperative increase in intraocular pressure, development of cystoid macular oedema, macular pucker, strabismus) a... · people with simple rhegmatogenous retinal detachments
Pars plana vitrectomy (PPV) may leads to higher adverse effects (cataract development, choroidal detachment,… compared with scleral buckling (low certainty).
1 finding from 1 review
Dry eye symptoms, measured using the OSDI score (ranging from 0 to 100 units, with a reduction in scores indicating clinical improvement) at 1‐month (with actual · people with dry eye
1 finding from 1 review
Ocular surface staining · people with dry eye
1 finding from 1 review
Aqueous tear production · people with dry eye
1 finding from 1 review
Tear film stability · people with dry eye
1 finding from 1 review
Frequency of artificial tear usage at 6 months · people with dry eye
1 finding from 1 review
Conjunctival goblet cell density (cells per unit) at 6 months · people with dry eye
1 finding from 1 review
Treatment related adverse events, · people with dry eye
1 finding from 1 review
Change in dry eye symptoms, measured using the OSDI score (ranging from 0 to 100 units, with a reduction in score indicating clinical improvement) at 1‐month (with actual · people with dry eyea
Oral long‐chain omega‐3 PUFAs (ie, EPA and DHA) showed no clear difference in change in dry eye symptoms, measured using the OSDI score (ranging… compared with placebo or no treatment (low certainty).
1 finding from 1 review
Tear film stability · people with dry eyea
Combined oral omega‐3 and omega‐6 PUFAs showed no clear difference in change in tear film stability, measured using tear break‐up time… compared with placebo (moderate certainty).
1 finding from 1 review
Change in tear osmolarity (measured in mOsmol/L, with reductions in osmolarity indicating clinical improvement) at 1‐month (with actual · people with dry eyea
1 finding from 1 review